-
Product Insights
Rabies – Drugs In Development, 2023
Global Markets Direct’s, ‘Rabies - Drugs In Development, 2023’, provides an overview of the Rabies pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rabies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2023
Global Markets Direct’s, ‘Ebolavirus Infections (Ebola Hemorrhagic Fever) - Drugs In Development, 2023’, provides an overview of the Ebolavirus Infections (Ebola Hemorrhagic Fever) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ebolavirus Infections (Ebola Hemorrhagic Fever), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Durvalumab in Non-Hodgkin Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Durvalumab in Non-Hodgkin Lymphoma Drug Details: Durvalumab (MEDI-4736, Imfinzi, Fidursi, Imfinzio) a programmed death-ligand 1...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Decitabine + Tetrahydrouridine) in Beta Thalassaemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Decitabine + Tetrahydrouridine) in Beta Thalassaemia Drug Details: Decitabine in combination with tetrahydrouridine is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eftozanermin Alfa in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eftozanermin Alfa in Pancreatic Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Eftozanermin Alfa in Pancreatic Cancer Drug Details:Eftozanermin alfa (ABBV-621) is under development...
-
Product Insights
Zhejiang Yisheng Petrochemical Company Ningbo Complex, China
Zhejiang Yisheng Petrochemical Company Ningbo Complex is located in Zhejiang, China. It started operations in 2005. Empower your strategies with our Zhejiang Yisheng Petrochemical Company Ningbo Complex, China report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
Zhejiang Yisheng Petrochemical Company Yangpu Complex, China
Zhejiang Yisheng Petrochemical Company Yangpu Complex is located in Hainan, China. It started operations in 2013. Empower your strategies with our Zhejiang Yisheng Petrochemical Company Yangpu Complex, China report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
Hainan Yisheng Petrochemical Yangpu Complex, China
Hainan Yisheng Petrochemical Yangpu Complex is proposed to be built in Hainan, China. It is expected to come online in 2025. Empower your strategies with our Hainan Yisheng Petrochemical Yangpu Complex, China report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based...
-
Product Insights
Yisheng Dahua Petrochemical Company Dalian Complex, China
Yisheng Dahua Petrochemical Company Dalian Complex is located in Liaoning, China. It started operations in 2009. Empower your strategies with our Yisheng Dahua Petrochemical Company Dalian Complex, China report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...